Literature DB >> 32636307

BMP-1 disrupts cell adhesion and enhances TGF-β activation through cleavage of the matricellular protein thrombospondin-1.

Cyril Anastasi1, Patricia Rousselle1, Maya Talantikite1, Agnès Tessier1, Caroline Cluzel1, Alice Bachmann1, Natacha Mariano1, Mélissa Dussoyer1, Lindsay B Alcaraz2, Laëtitia Fortin1, Alexandre Aubert1, Frédéric Delolme1,3, Naïma El Kholti1, Jean Armengaud4, Pierre Fournié5,6, Céline Auxenfans1,7, Ulrich Valcourt1,2, Sandrine Vadon-Le Goff1, Catherine Moali8.   

Abstract

Bone morphogenetic protein 1 (BMP-1) is an important metalloproteinase that synchronizes growth factor activation with extracellular matrix assembly during morphogenesis and tissue repair. The mechanisms by which BMP-1 exerts these effects are highly context dependent. Because BMP-1 overexpression induces marked phenotypic changes in two human cell lines (HT1080 and 293-EBNA cells), we investigated how BMP-1 simultaneously affects cell-matrix interactions and growth factor activity in these cells. Increasing BMP-1 led to a loss of cell adhesion that depended on the matricellular glycoprotein thrombospondin-1 (TSP-1). BMP-1 cleaved TSP-1 between the VWFC/procollagen-like domain and the type 1 repeats that mediate several key TSP-1 functions. This cleavage induced the release of TSP-1 C-terminal domains from the extracellular matrix and abolished its previously described multisite cooperative interactions with heparan sulfate proteoglycans and CD36 on HT1080 cells. In addition, BMP-1-dependent proteolysis potentiated the TSP-1-mediated activation of latent transforming growth factor-β (TGF-β), leading to increased signaling through the canonical SMAD pathway. In primary human corneal stromal cells (keratocytes), endogenous BMP-1 cleaved TSP-1, and the addition of exogenous BMP-1 enhanced cleavage, but this had no substantial effect on cell adhesion. Instead, processed TSP-1 promoted the differentiation of keratocytes into myofibroblasts and stimulated production of the myofibroblast marker α-SMA, consistent with the presence of processed TSP-1 in human corneal scars. Our results indicate that BMP-1 can both trigger the disruption of cell adhesion and stimulate TGF-β signaling in TSP-1-rich microenvironments, which has important potential consequences for wound healing and tumor progression.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Year:  2020        PMID: 32636307     DOI: 10.1126/scisignal.aba3880

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  5 in total

Review 1.  Thrombospondin-1 Signaling Through the Calreticulin/LDL Receptor Related Protein 1 Axis: Functions and Possible Roles in Glaucoma.

Authors:  Joanne E Murphy-Ullrich
Journal:  Front Cell Dev Biol       Date:  2022-05-27

2.  Latent TGF-β Activation Is a Hallmark of the Tenascin Family.

Authors:  Alexandre Aubert; Perrine Mercier-Gouy; Stéphanie Aguero; Laurent Berthier; Sophie Liot; Laura Prigent; Lindsay B Alcaraz; Bernard Verrier; Raphaël Terreux; Catherine Moali; Elise Lambert; Ulrich Valcourt
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

Review 3.  The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications.

Authors:  Tatjana Bordukalo-Nikšić; Vera Kufner; Slobodan Vukičević
Journal:  Front Immunol       Date:  2022-04-26       Impact factor: 8.786

Review 4.  Transforming growth factor β latency: A mechanism of cytokine storage and signalling regulation in liver homeostasis and disease.

Authors:  Yujia Li; Weiguo Fan; Frederik Link; Sai Wang; Steven Dooley
Journal:  JHEP Rep       Date:  2021-11-18

Review 5.  SCO-spondin, a giant matricellular protein that regulates cerebrospinal fluid activity.

Authors:  Vania Sepúlveda; Felipe Maurelia; Maryori González; Jaime Aguayo; Teresa Caprile
Journal:  Fluids Barriers CNS       Date:  2021-10-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.